Poseida Therapeutics, Inc. (PSTX)
9.50
0.00 (0.00%)
USD |
NASDAQ |
Jan 08, 16:00
Poseida Therapeutics Max Drawdown (5Y)
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| December 31, 2024 | 90.03% |
| November 30, 2024 | 90.03% |
| October 31, 2024 | 90.03% |
| September 30, 2024 | 90.03% |
| August 31, 2024 | 90.03% |
| July 31, 2024 | 90.03% |
| June 30, 2024 | 90.03% |
| May 31, 2024 | 90.03% |
| April 30, 2024 | 90.03% |
| March 31, 2024 | 90.03% |
| February 29, 2024 | 90.03% |
| January 31, 2024 | 90.03% |
| December 31, 2023 | 90.03% |
| November 30, 2023 | 90.03% |
| October 31, 2023 | 90.03% |
| September 30, 2023 | 90.03% |
| August 31, 2023 | 90.03% |
| July 31, 2023 | 89.91% |
| June 30, 2023 | 89.78% |
| May 31, 2023 | 88.49% |
| April 30, 2023 | 88.49% |
| March 31, 2023 | 88.49% |
| February 28, 2023 | 88.49% |
| January 31, 2023 | 88.49% |
| December 31, 2022 | 88.49% |
| Date | Value |
|---|---|
| November 30, 2022 | 88.49% |
| October 31, 2022 | 88.49% |
| September 30, 2022 | 88.49% |
| August 31, 2022 | 88.49% |
| July 31, 2022 | 88.49% |
| June 30, 2022 | 88.49% |
| May 31, 2022 | 88.49% |
| April 30, 2022 | 81.72% |
| March 31, 2022 | 80.18% |
| February 28, 2022 | 78.31% |
| January 31, 2022 | 72.37% |
| December 31, 2021 | 61.66% |
| November 30, 2021 | 61.66% |
| October 31, 2021 | 61.66% |
| September 30, 2021 | 56.37% |
| August 31, 2021 | 51.02% |
| July 31, 2021 | 51.02% |
| June 30, 2021 | 51.02% |
| May 31, 2021 | 51.02% |
| April 30, 2021 | 50.22% |
| March 31, 2021 | 50.22% |
| February 28, 2021 | 50.22% |
| January 31, 2021 | 50.22% |
| December 31, 2020 | 50.22% |
| November 30, 2020 | 50.22% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| AbbVie, Inc. | 21.89% |
| Abeona Therapeutics, Inc. | 99.58% |
| America Great Health | 100.00% |
| Acumen Pharmaceuticals, Inc. | 95.56% |
| Aardvark Therapeutics, Inc. | -- |